Table 1.13

Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years

Survival (%)

Organ and Survival Type Follow-up Period
3 Months 1 Year 3 Years 5 Years 10 Years
Tx 2004-2005 Tx 2004-2005 Tx 2002-2005 Tx 2000-2005 Tx 1995-2005
Kidney: Deceased Donor Graft Survival 94.7% 90.0% 78.9% 67.5% 41.8%
Patient Survival 98.0% 94.8% 88.4% 80.6% 60.9%
Kidney: Living Donor Graft Survival 97.3% 95.1% 88.5% 80.2% 57.7%
Patient Survival 99.3% 98.0% 94.7% 90.3% 77.0%
Pancreas Alone Graft Survival 90.2% 80.1% 55.9% 50.6% 26.7%
Patient Survival 99.0% 96.7% 91.9% 88.1% 70.6%
Pancreas After Kidney Graft Survival 85.9% 78.5% 66.1% 58.1% 28.6%
Patient Survival 98.8% 96.6% 90.5% 83.9% 63.6%
Kidney-Pancreas Kidney Graft Survival 95.9% 92.9% 85.5% 77.9% 55.2%
Pancreas Graft Survival 90.2% 86.2% 79.8% 72.5% 54.2%
Patient Survival 97.4% 95.0% 91.2% 86.1% 70.0%
Liver: Deceased Donor Graft Survival 89.6% 82.3% 73.7% 67.6% 53.3%
Patient Survival 93.2% 86.9% 78.9% 73.6% 59.5%
Liver: Living Donor Graft Survival 90.0% 84.1% 77.1% 68.6% 65.2%
Patient Survival 95.4% 90.6% 83.8% 76.1% 73.4%
Intestine Graft Survival 83.5% 73.4% 54.3% 36.9% 23.4%
Patient Survival 91.4% 81.0% 67.4% 53.6% 42.5%
Heart Graft Survival 91.7% 87.3% 79.3% 73.2% 52.4%
Patient Survival 92.2% 87.8% 80.2% 74.4% 54.1%
Lung Graft Survival 91.8% 82.3% 65.4% 49.7% 24.3%
Patient Survival 92.7% 84.0% 68.0% 52.6% 26.6%
Heart-Lung Graft Survival 81.9% 75.0% 54.8% 49.3% 29.3%
Patient Survival 81.9% 75.0% 56.3% 49.7% 30.6%
Kidney-Liver Kidney Graft Survival 86.9% 77.7% 70.9% 62.0% 45.9%
Liver Graft Survival 87.0% 78.2% 71.2% 64.4% 51.3%
Patient Survival 92.3% 83.7% 77.1% 72.7% 57.3%
Kidney-Heart Heart Graft Survival 89.3% 83.4% 80.5% 72.7% 46.8%
Kidney Graft Survival 89.1% 82.9% 78.0% 64.8% 36.7%
Patient Survival 88.5% 80.8% 79.6% 75.7% 50.3%
Liver-Intestine Intestine Graft Survival 87.5% 75.0% 69.0% 55.5% 36.2%
Liver Graft Survival 87.5% 75.0% 68.2% 55.7% 36.1%
Patient Survival 89.5% 76.3% 70.1% 58.1% 38.1%


Source: OPTN/SRTR Data as of May 1, 2007.

Multi-organ transplants are excluded except where specified. Living donor transplants excluded unless explicitly listed. Heterotopic heart and liver transplants excluded.

Graft survival follows individual transplants until graft failure. Patient survival follows patients from first transplant of this type until death.